199 related articles for article (PubMed ID: 35695656)
1. Statin-related adverse drug reactions in UK primary care consultations: A retrospective cohort study to evaluate the risk of cardiovascular events and all-cause mortality.
Insani WN; Whittlesea C; Ju C; Man KKC; Alwafi H; Alsharif A; Chapman S; Wei L
Br J Clin Pharmacol; 2022 Nov; 88(11):4902-4914. PubMed ID: 35695656
[TBL] [Abstract][Full Text] [Related]
2. Impact of ACEIs and ARBs-related adverse drug reaction on patients' clinical outcomes: a cohort study in UK primary care.
Insani WN; Whittlesea C; Ju C; Man KK; Adesuyan M; Chapman S; Wei L
Br J Gen Pract; 2023 Nov; 73(736):e832-e842. PubMed ID: 37783509
[TBL] [Abstract][Full Text] [Related]
3. Impact of statin discontinuation on mortality in patients with rheumatoid arthritis: a population-based study.
De Vera MA; Choi H; Abrahamowicz M; Kopec J; Lacaille D
Arthritis Care Res (Hoboken); 2012 Jun; 64(6):809-16. PubMed ID: 22467274
[TBL] [Abstract][Full Text] [Related]
4. Statin use and outcome risks according to predicted CVD risk in Korea: A retrospective cohort study.
Jung HH
PLoS One; 2021; 16(1):e0245609. PubMed ID: 33450746
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular and Renal Morbidity in Takayasu Arteritis: A Population-Based Retrospective Cohort Study From the United Kingdom.
Goel R; Chandan JS; Thayakaran R; Adderley NJ; Nirantharakumar K; Harper L
Arthritis Rheumatol; 2021 Mar; 73(3):504-511. PubMed ID: 32969145
[TBL] [Abstract][Full Text] [Related]
6. Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study.
Ramos R; Comas-Cufí M; Martí-Lluch R; Balló E; Ponjoan A; Alves-Cabratosa L; Blanch J; Marrugat J; Elosua R; Grau M; Elosua-Bayes M; García-Ortiz L; Garcia-Gil M
BMJ; 2018 Sep; 362():k3359. PubMed ID: 30185425
[TBL] [Abstract][Full Text] [Related]
7. The effect of statins on mortality and cardiovascular disease in primary care hypertensive patients without other cardiovascular disease or diabetes.
Andersson T; Nåtman J; Mourtzinis G; Bager JE; Bengtsson Boström K; Franzén S; Hjerpe P
Eur J Prev Cardiol; 2023 Nov; 30(17):1883-1894. PubMed ID: 37368941
[TBL] [Abstract][Full Text] [Related]
8. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.
Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766
[TBL] [Abstract][Full Text] [Related]
9. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
Lee J; Lee S
Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
[TBL] [Abstract][Full Text] [Related]
10. Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older.
Orkaby AR; Driver JA; Ho YL; Lu B; Costa L; Honerlaw J; Galloway A; Vassy JL; Forman DE; Gaziano JM; Gagnon DR; Wilson PWF; Cho K; Djousse L
JAMA; 2020 Jul; 324(1):68-78. PubMed ID: 32633800
[TBL] [Abstract][Full Text] [Related]
11. Statin induced myopathy and myalgia: time trend analysis and comparison of risk associated with statin class from 1991-2006.
Molokhia M; McKeigue P; Curcin V; Majeed A
PLoS One; 2008 Jun; 3(6):e2522. PubMed ID: 18575628
[TBL] [Abstract][Full Text] [Related]
12. The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease.
Lafeber M; Spiering W; van der Graaf Y; Nathoe H; Bots ML; Grobbee DE; Visseren FL
Am Heart J; 2013 Aug; 166(2):282-289.e1. PubMed ID: 23895811
[TBL] [Abstract][Full Text] [Related]
13. Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: a large UK cohort study.
Anyanwagu U; Mamza J; Donnelly R; Idris I
Cardiovasc Diabetol; 2017 Aug; 16(1):107. PubMed ID: 28830436
[TBL] [Abstract][Full Text] [Related]
14. Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies.
Awad K; Mohammed M; Zaki MM; Abushouk AI; Lip GYH; Blaha MJ; Lavie CJ; Toth PP; Jukema JW; Sattar N; Banach M;
BMC Med; 2021 Jun; 19(1):139. PubMed ID: 34154589
[TBL] [Abstract][Full Text] [Related]
15. Short- and long-term association of lipid-lowering drug treatment and cardiovascular disease by estimated absolute risk in the Second Australian National Blood Pressure study.
Ho CLB; Chowdhury EK; Breslin M; Doust J; Reid CM; Wing LMH; Nelson MR;
J Clin Lipidol; 2019; 13(1):148-155. PubMed ID: 30293937
[TBL] [Abstract][Full Text] [Related]
16. Use of statin for the primary prevention of cardiovascular outcomes in elderly patients: A propensity-matched cohort study.
Cho Y; Jeong Y; Seo DH; Ahn SH; Hong S; Suh YJ; Kim SH
Atherosclerosis; 2021 Jul; 328():92-99. PubMed ID: 34126505
[TBL] [Abstract][Full Text] [Related]
17. Determining propensity for sub-optimal low-density lipoprotein cholesterol response to statins and future risk of cardiovascular disease.
Weng SF; Akyea RK; Man KK; Lau WCY; Iyen B; Blais JE; Chan EW; Siu CW; Qureshi N; Wong ICK; Kai J
PLoS One; 2021; 16(12):e0260839. PubMed ID: 34855879
[TBL] [Abstract][Full Text] [Related]
18. Effect of statin use on cardiovascular events and all-cause mortality in immune-mediated inflammatory diseases: A systematic review and meta-analysis involving 148,722 participants.
Xie W; Huang H; Xiao S; Yang X; Zhang Z
Pharmacol Res; 2020 Oct; 160():105057. PubMed ID: 32619724
[TBL] [Abstract][Full Text] [Related]
19. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Chou R; Cantor A; Dana T; Wagner J; Ahmed AY; Fu R; Ferencik M
JAMA; 2022 Aug; 328(8):754-771. PubMed ID: 35997724
[TBL] [Abstract][Full Text] [Related]
20. Statin use for primary prevention in patients with type 2 diabetes: Can it benefit all ages? - A nationwide propensity-matched cohort study.
Jun JE; Jeong IK; Ahn KJ; Chung HY; Hwang YC
Diabetes Res Clin Pract; 2021 Oct; 180():109044. PubMed ID: 34508736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
